AMBIT BIOSCIENCES CORP

Inactive Instrument

Ambit Biosciences Corp Stock

Equities

US02318X1000

Pharmaceuticals

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2014

DAIICHI SANKYO : Japan's Daiichi Sankyo to acquire US biopharma Ambit Biosciences

RE

Latest news about Ambit Biosciences Corp

DAIICHI SANKYO : Japan's Daiichi Sankyo to acquire US biopharma Ambit Biosciences

14-09-28

RE

Press releases Ambit Biosciences Corp

Ambit Biosciences : Daiichi Sankyo and Ambit Announce Results of Tender Offer	14-11-10	PR
Ambit Biosciences : Announces Expiration of Hart-Scott-Rodino Waiting Period	14-10-28	PR
Ambit Biosciences : Announcement Regarding Submission of Tender Offer for Shares in Ambit Biosciences Corporation	14-10-14	PR
Ambit Biosciences : Stockholders Encouraged to Contact Securities Law Firm about Takeover	14-10-01	PR
Ambit Biosciences : Ryan & Maniskas, LLP : Announces Investigation of Ambit Biosciences Corporation	14-10-01	PR

More press releases

Managers and Directors - Ambit Biosciences Corp

Managers	Title	Age	Since
Ken Takeshita CEO	Chief Executive Officer	-	-

Members of the board	Title	Age	Since
Kenneth Joseph Keller BRD	Director/Board Member	61	14-11-09
Michael Martino CEO	Chief Executive Officer	68	11-11-15
Glenn Gormley BRD	Director/Board Member	-	14-11-09

Company Profile

Sector

Pharmaceuticals

More about the company

Sector Biopharmaceuticals

	1st Jan change	Capi.
CSL LIMITED	-5.99%	84.46B
SAMSUNG BIOLOGICS CO.,LTD.	+2.76%	40.85B
BIOGEN INC.	-24.88%	27.69B
UCB	+53.61%	24.28B
BIOMARIN PHARMACEUTICAL INC.	-8.08%	17.09B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-33.74%	13.67B
INCYTE CORPORATION	-16.63%	11.86B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-11.19%	11.79B
SWEDISH ORPHAN BIOVITRUM AB	-2.25%	8.07B

Biopharmaceuticals

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer